Is Better Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: BTTX) stock is to Strong Buy BTTX stock.
Out of 2 analysts, 2 (100%) are recommending BTTX as a Strong Buy, 0 (0%) are recommending BTTX as a Buy, 0 (0%) are recommending BTTX as a Hold, 0 (0%) are recommending BTTX as a Sell, and 0 (0%) are recommending BTTX as a Strong Sell.
What is BTTX's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: BTTX) forecast ROE is N/A, which is considered weak.
What is BTTX's Price Target?
According to 2 Wall Street analysts that have issued a 1 year BTTX price target, the average BTTX price target is $7.00, with the highest BTTX stock price forecast at $9.00 and the lowest BTTX stock price forecast at $5.00.
On average, Wall Street analysts predict that Better Therapeutics's share price could reach $7.00 by Apr 14, 2024. The average Better Therapeutics stock price prediction forecasts a potential upside of 853.68% from the current BTTX share price of $0.73.
What is BTTX's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: BTTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.